Intellia Therapeutics, Inc. (NTLA)

Intellia Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	156.17	189.18	226.75	523.51	123.41	160.02
Short-Term Investments	303.48	412.33	685.48	669.12	625.28	437.35
Cash & Short-Term Investments	459.65	601.52	912.22	1,193	748.69	597.37
Cash Growth	-33.49%	-34.06%	-23.51%	59.29%	25.33%	113.56%
Receivables	11.35	8.52	36.46	3.77	2.03	2.13
Prepaid Expenses	24.94	29.83	47.55	20.41	18.58	14.32
Restricted Cash	-	-	-	-	-	2.7
Other Current Assets	-	-	2.1	-	-	-
Total Current Assets	495.95	639.86	998.33	1,217	769.3	616.52
Property, Plant & Equipment	151.85	246.67	148.14	161	100.11	55.06
Long-Term Investments	196.94	287.09	136.39	126.59	420.29	0.16
Other Long-Term Assets	54.16	17.39	18.12	15.73	4.76	4.59
Total Assets	898.89	1,191	1,301	1,520	1,294	676.32
Accounts Payable	9.8	14.59	7.45	5.15	9.65	10.46
Accrued Expenses	41.55	55.36	60.13	60.88	43.31	25.55
Current Portion of Leases	26.99	20.25	18.6	16.69	9.11	5.7
Current Unearned Revenue	17.15	20.66	22.14	43.84	63.76	22.54
Other Current Liabilities	-	-	6.89	-	-	-
Total Current Liabilities	95.5	110.85	115.21	126.55	125.83	64.25
Long-Term Leases	75.6	189.95	96.75	114.02	64.91	33.61
Long-Term Unearned Revenue	12.54	18.26	38.85	19.93	63.48	51.39
Other Long-Term Liabilities	-	-	-	24.03	-	-
Total Liabilities	183.64	319.06	250.81	284.53	254.22	149.25
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	3,108	3,049	2,711	2,420	1,746	962.17
Retained Earnings	-2,393	-2,177	-1,658	-1,177	-703	-435.11
Comprehensive Income & Other	0.65	0.61	-2.26	-7.46	-2.63	0
Total Common Equity	715.26	871.96	1,050	1,236	1,040	527.07
Shareholders' Equity	715.26	871.96	1,050	1,236	1,040	527.07
Total Liabilities & Equity	898.89	1,191	1,301	1,520	1,294	676.32
Total Debt	102.59	210.2	115.35	130.7	74.02	39.31
Net Cash (Debt)	527.92	651.53	896.74	1,131	1,012	558.07
Net Cash Growth	-36.67%	-27.34%	-20.73%	11.78%	81.34%	109.72%
Net Cash Per Share	5.15	6.59	10.10	14.70	14.28	9.97
Filing Date Shares Outstanding	107.35	103.52	96.11	88.02	74.67	67.73
Total Common Shares Outstanding	105.33	102.03	93	87.1	74.49	66.23
Working Capital	400.45	529.01	883.12	1,090	643.47	552.26
Book Value Per Share	6.79	8.55	11.29	14.19	13.97	7.96
Tangible Book Value	715.26	871.96	1,050	1,236	1,040	527.07
Tangible Book Value Per Share	6.79	8.55	11.29	14.19	13.97	7.96
Machinery	-	71.97	67.59	56.33	43.34	32.7
Leasehold Improvements	-	3.2	3.13	3.07	2.19	1.52

Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q